Accepted papers in 2nd International Personalized Medical Congress

• Predictive role of genetic variants in neoadjuvant chemotherapy of breast cancer

• miRNAs in pathogenesis, prognosis, and directed therapies of chronic lymphocytic leukemia (CLL)

• Most used microRNA in inflammatory bowel disease

• Groth hormone and cancer risk

• Interaction between obesity-related MC4R (Rs17782313) gene, associated to an increase of Breast Cancer risk.

• Mir-21 is a New Biomarker for Personalized Oncology

• Proteoglycans and Colorectal Cancer: A review Study

• Proteoglycans in Gastric Cancer: A review Study

• The impact of health information technology in promotion of personalized medicine

• The therapeutic application of lipase, as an effective drug in the prevention, treatment and improvement of cancer progress

• Association Micro-RNA 125 and Micro-RNA 152 Polymorphisms with Long Cancer Risk in Iranian Patients

• Effect of Fucoidan Extracted from Algae on Colon Cancer

• Multi-dimensional model of hospital and healthcare environment for patients with cancer and their family

• AKT2, miRNA and Tumorogenesis

• Tumor associated macrophages (TAMs) target for cancer treatment: new promising route in cancer immunotherapy

• Apoptosis assessment of the essential oil from the fruits of Pycnocycla bashagardiana Mozaff. in HT-29 cells: Association with expression Bcl-2 and Bax

• Nutrigenomics and Breast Cancer

• Progress in human tumour immunology and cancer immunotherapy

• The Effect of Thymoquinone on Level of FOXM1 mRNA in Glioblastoma

• Topology of personalized opsonization: revealing a pattern of cancerous differential geometry

• Study of BMI-1 gene expression in breast cancer tumor tissue and its relationship with cilinopathological markers

• Investigation of rs 515135 and rs 639 varation in APOB gen in Familial hypercholesterolemia patients with comparison to the healthy controls

• Investigating the concomitant expression alteration of long non-coding RNAs GNAS-AS1 and BLACAT1 of breast cancer specimen

• Investigation of DLEC1 gene methylation pattern in the human colorectal cancer cell line HT29 engineered by E- cadherin stable down regulation

• The role of personal medicine in the diagnostic and treatment of cancer

• Association of Genetic polymorphism in estrogen metabolism and susceptibility to Breast cancer

• Cervical cancer, HPV and personalized medicine

• New challenges in cancer personalized medicine: from identifying mutation to precise modification

• Study expression balance of miRNA‐196a‐2 tumor marker in ovarian cancer patients by Real Time PCR:

• Compare the Effectiveness of Group Logo therapy and Solution- Focused Brief Therapy in the Quality Life of women with Breast Cancer

• Gynecomastia, as an extremely rare presentation of chest wall lymphoma, a case report and review the articles

• Exosome based Technology in Personalized Cancer Medicine

• MicroRNAs expression signatures as a novel approach in cancer detection

• Personalized forensic toxicology: the promises of pharmacogenomics in the interpretation of drug poisonings

• Cell-based drug delivery; a new trend in personalized medicine

• Majority of TP53 signaling pathway related genes are up-regulated in Tamoxifen-treated MCF-7 human Breast adenocarcinoma cell line

• Evaluate of influential factors affecting survival of patients with Leukemia cancer using Logistic Regression model

• Expression evaluation of cell cycle regulatory genes (P27, P21, P14) in AML patient

• Melanoma and microRNAs; remarkable relationship

• Can seasonal Variations affect breast cancer (Review)

• Personalize medicine: New epigenetic mechanisms of differentiation umbilical cord mesenchymal stem cells to neural stem-like cells

• Association of body mass index and waist circumference with bone metabolism markers in Iranian elderly

• CRISPR/Cas9-mediated Genome Editing

• A meta-analysis on vitamin D level and vitamin D deficiency with risk of preeclampsia: an approach to individualized therapy

• Limitations and solutions in precision medicine for Breast cancer

• Personalized medicine in treatment of prostate cancer

• Biomarkers for the management of Prostate cancer

• MicroRNA-based therapies: Small biomarkers with big clinical application

• Classifying the Evolutionary and Ecological features of Neoplasms

• A novel stop-gain mutation in the MSH2 gene among a Persian family fulfilling classic Amsterdam criteria for Lynch syndrome

• MicroRNAs: New Powerful Weapons in Personalized Colon Cancer Treatment

• Targeted therapy in metastatic differentiated thyroid Carcinoma (DTC)

• Inhalation exposure of Biological barrier nanoparticle induced oxidative stress in Au

• Inhalation exposure of diamond nanoparticle induced oxidative stress in melanoma

• Inhalation exposure of Graphene nanoparticle induced oxidative stress in Melanoma

• Role of radiation oncology in precision medicine

• The role of Precision Medicine in controlling of OSCC according to ethnicity

• miRNA Antagonists: a new strategy to cancer and other diseases treatment

• Human Cancer Modeling: effects of tumor heterogeneity on personalized medicine

• Down-regulated MicroRNA 148a expression as predictive biomarker in lung cancer

• Reciprocal relationship between epi-miRNAs and Epigenetic Modifications in cancer

• Exosomal proteins as a new approach in cancer diagnosis

• The role of personalized medicine in Head and Neck cancer

• Use of the next-generation functional diagnostics in cancer precision medicine

• Personalized sequencing for Treatment of colorectal cancer, forward personalized medicine: recent advances and future challenges

• Studying the relation of blood lead level with the thyroid hormone concentrations and blood cell count

• Personalized medicine in breast cancer

• The effect of personal medicine with analysis epigenetics biomarkers and changes of miRNA expression profile in diagnosis and treatment of prostate cancer

• Genetic polymorphism of CENP-E and susceptibility colorectal cancer in Ahvaz

• Frequencies of common CYP2D6 alleles and genotypes within Isfahan population of Iran

• Bioinformatics study in personal medicine of medulloblastoma

• study of prostate cancer metastasis in bone

• The exosomal microRNA as reliable biomarker to early detection of pancreatic cancer

• Genetic Variations of CHRNA5 Gene Correlated to High Risk of Lung Cancer in Iranian Patients

• A novel mutation in pkhd1 gene in an Iranian family with an abortion affected with Autosomal Recessive polycystic kidney disease

• The anticancer activity of metformin through microRNAs modulation

• Breast Cancer During Pregnancy:

• A genetic polymorphism in rs1801133 in MTHFR, rs10811661 in CDKN2A/B genes associated with breast cancer

• Circulating miRNA-containing Exosomes as potential biomarkers for diagnosis and monitoring of breast cancer

• Organoids transplantation, the new model to speed up personalized medicine researches in Colon cancer and metastasis

• Tissue Engineered Cells in Breast Cancer

• Concentration of CEA, CA-125 and CA19-9 tumor markers in sulfur mustard exposed veterans

• Can sulfur mustard effects on Alpha fetoprotein and β-human chorionic gonadotropin tumor markers in exposed veterans

• Diagnosis of Circular Cancer Stem Cell by Microfluidic System

• challenges and opportunities of Breast cancer personalized medicine

• Circulating tumor cells in individualized cancer treatment

• Oxidative stress and mitochondrial dysfunctions in personalized cancerous signalling pathway

• Cancer Stem Cell

• Effects of Vasectomy on Prostate Cancer Rate (Review)

• Methodology of paradigm shift towards personalized medicine

• A novel approach to personalized cancer treatment with electricinduced field emission materials

• Evaluation and comparison of the effect of anti-SALL4 siRNA on growth and sensitivity of the colorectal cancer cell line

• Cancerous Women Personal Health Record

• Microfluidic approaches for separation of Mouse Tumoral Cells from Neonate Spermatogonial Cells Suspensions

• Role of Micro-RNAs in Growth Hormone Deficiency: the Current Evidence

• The emergence of micro-isolator devices for high throughput exosome analysis: A technological leap towards personalized cancer treatment

• Metabolomics and Personalized Medicine: Benefits and Challenges in Undeveloped Countries

• The interaction between Berberine chloride with complex Histone(H1)- DNA by multi spectroscopic and molecular modeling

• Expression of micro RNAs implicated in left ventricular hypertrophy; a systematic review

• A comprehensive model for cancer prevention and early detection

• Personalized micro-RNA profiling and their individualized theranostic applications in cancer treatment

• Personal tumor neoantigens and cancer immunotherapy

• Producing Taxol from Iranian Yew

• Epigenetic alterations in hematologic malignancies

• Effect of mutation in exon.4 of the LDL Receptor gene (LDLR) in familial hypercholesterolemia

• The cytotoxicity effect of Nigella Sativa extract and Thymoquinone on SW480 human colon cancer cell line

• Molecular Genetic of Familial Hypercholesterolemia and Personalized Medicine

• Gene Expression Profiles in Radiation Workers Occupationally Exposed to Low Levels of Ionizing Radiation in Al-Tuwaitha Site in Baghdad

• Recent update on checkpoint inhibitors for cancer immune therapy

• Summary of topics provided in the panel

• Personalized medicine in hematologic malignancy

• Impact of microsatellite status ( MSI ) with KRAS/NRAS and BRAF mutations for a colorectal cancer, a case report

• The effect of naturally-occurring dietary compounds on Cancer Stem Cells

• The Effect of CXCR4-siRNA Nanoparticles on serum ALP and LDH levels in a mouse model of colorectal cancer Metastasis to the liver

• Probiotics and suppression of cancer

• Cell therapy in diabetic foot ulcer

• Epigenetic modifications by dietary polyphenols in cancer

• Application of personalized medicine to chronic disease: Metabolic syndrome

• Personalized medicine in acute leukemia

• Circulating tumor cells as a novel cellular biomarker in breast cancer

• Circulating tumor DNA as an early marker of therapeutic in patients with metastatic colorectal cancer

• Using zebrafish models of rare diseases to accelerate orphan drug discovery

• Personalized Care in Colorectal Cancer

• Molecular signaling in nonfunctional pituitary adenoma

• The importance of precision medicine for cancer patients

• Advanced Differentiated Thyroid Cancer: Molecular Targeted Therapies

• Personalized Medicine in Gastroenterology Disorders

• Application of Network Science in Drug‐Protein‐Disease Interaction and Drug Repositioning

• Drug resistance and personalized medicine

• Personalized treatment in colon cancer

• Immunotherapy in colon cancer

• Guided management for Cancer

• Clinical proteomics in cancer: a focus on personalized medicine

• Genomic Diagnostics of Cancer

• Recombinant Antibody and CAR‐T cell cancer Therapy

• Molecular biology of colorectal cancer & Antiepidermal growth factor receptor therapies

• Multiple myeloma -a heterogeneous challenge

• A Novel Approach to the Nutrigenetics and Nutrigenomics of Breast Cancer

• Nutrigenomics of Omega 3 fatty acids

• Personalized Medicine in Pediatric Cancer

• Rare genetic variants in DNA repair genes in BRCA1 mutation carriers with early and late age at onset of breast cancer

• Mechanistic studies on ribonucleotide reductase regulation and DNA damage response-application in cancer research

• Thwarting PTEN Expression by siRNA Augments HL-60 Cell Differentiation to Neutrophil-Like Cells by DMSO and ATRA

• Autologous Targeted Exosomes as a Drug Delivery System

• Personalized Cancer Medicine: a Future Direction of Personal Genomics

• What are essential dimensions of personalized medicine which should be considered in policy making A comparative study

• Assessment of micronuclei frequency in the peripheral blood lymphocytes in patients with gastric cancer before and after chemotherapy treatment

• Prediction of drug sensitivity in AML subtypes in response to Mitoxantrone from global gene expression, an impact on personalized cancer chemotherapy

• Altered expression of TGF-beta signaling pathway components contributes to acute myeloid leukemia

• Targeting the core regulatory network of stemness in an in vitro AML model using a GRN approach

• Hematopoietic Differentiation of Induced Pluripotent Stem Cells (iPSCs) derived from Glioblastoma Cell Lines

• The Effects of Anti-angiogenesis on Enoxaparin Cutaneous Emulsion on Induced Breast Cancer in Female Rats

• Early cancer detection based on guanine oxidation consequent to the hybridization between miRNA-21 and it s inosine substitute capture probe

• Use of Biomarker Assessment of Nicotine Metabolism in Estimating the Risk of Cancer in People Who Smoke Tobacco

• Mutational Analysis of FLT3 Internal Tandem Duplication and D835 in De novo Adult Acute Myeloid Leukemia

• MicroRNAs: Promising Molecules against Resistance to Breast Cancer Therapeutic Drugs

• Inhalation exposure of Manganese Dioxide nanoparticle induced oxidative stress in Melanoma

• A New Anti-Era36 scFv to diagnose the Tamoxifen Resistant Breast Cancer

• Challenges and Limitations of Personalized Medicine in the Treatment of Breast Cancer

• The new method of personalized chemotherapy with Notch inhibitor and mathematical model in melanoma mouse model

• Comparing the concentration of tamoxifen and its metabolites between different genotypes of CYP2D6 gene

• SOPHiA GENETICS: The AI Democratizing Data-Driven Medicine

• Prostate specific antigen in sulfur mustard exposed persons

• Personalized Medicine and Epidermal Growth Factor Receptor Mutation in Non‐Small Cell Lung Cancer: A study from National Research Institute of Tuberculosis and Lung Disease

• Non-coding RNAs miR-20a and miR-145 could differentiate between colon and rectum tumors

• New gene manipulation strategies against cancer stem cells

• Familial Osteosarcoma in a large pedigree: A case report

• Application of mesenchymal stem cell-based gene therapy in personalized treatment of gastrointestinal cancers

• Identification of expressional signature of Iranian Gastric cancer patients by next generation sequencing

• Palliative care for cancer patients

• Precision Medicine for Endocrinology

• Personalized lung cancer treatment

• An update of personalized medicine issues in breast cancer

• Personalized Medicine in Breast cancer: Where we are in practice

• Personalized medicine in diabetes

• Personalized Medicine In Metastatic Colon Cancer

• Pharmacogenomic management of malignancies using Integrated Clinical Genomics (ICG)

• Endocrinology and Precision Medicine

• Posttraumatic stress and posttraumatic growth Simultaneously in patients with breast cancer

• Ethics in Personalized Medicine

• Measuring the Genetic Damage in Some Iraqi Breast Cancer Patients During Chemotherapy with Three Genetic End-Points

• The effect of Conjugated linoleic acids on tumor cells suppression and probably mechanisms of their effect

• Thyroid Cancer and Personalized Medicine

• Early Detection of Breast Cancer using a Panel of Circulating miRNA